home *** CD-ROM | disk | FTP | other *** search
- Newsgroups: alt.psychoactives
- Path: sparky!uunet!haven.umd.edu!news.umbc.edu!gmuvax2!dstalder
- From: dstalder@gmuvax2.gmu.edu (Darren/Torin/Who ever...)
- Subject: Re: Ecstasy
- Message-ID: <1993Jan23.052411.27421@gmuvax2.gmu.edu>
- Summary: Ecstasy has not been found to be neurotoxic
- Organization: George Mason University, Fairfax, Va.
- References: <21579@ucdavis.ucdavis.edu> <1993Jan22.073132.3739@news.yale.edu>
- Date: Sat, 23 Jan 1993 05:24:11 GMT
- Lines: 86
-
- In article <1993Jan22.073132.3739@news.yale.edu> FRICHARD@biomed.med.yale.edu (Frank Richardson) writes:
- >On the contrary, I would say that it is quite neurotoxic. Ecstacy causes a
- >profound release of the neurotrasmitter serotonin. It over stimulates the
- >cells so much they usually die. In rodents, as much as 80% of the
- >serotonergic neurons were lost. Recall, neurons in your brain generally DO
- >NOT regenerate, so once they're gone....Sorry if I sound like a cop, I'm
- >not. Although it is true that no precise studies have been done in humans, I
- >wouldn't recommend X for the time being.
-
- I am going to take hunks from the December '92 issue of Gnosis in an article
- called "Ecstasy Revisited" by Bruce Eisner. He also has a book called
- _Ecstasy:__The_MDMA_Story (Berkeley CA: Ronin Publishing, 1989). Any
- typographic errors are mine. Hopefully this falls under fair use rules, this
- is kinda educational use.
-
- p. 57: 3rd and 4th paragraphs, 1st column
- The quesiton of MDMA's neutotoxicity was first raised in 1985, when George
- Ricarte and Charles Shuster at the University of Chicago performed an
- experiment in which rats were intravenously given very high doses (ten times
- the therapeutic does in humans) of MDA, a drug similar to MDMA, at four-hour
- intervals for two days. Changes were noted in the terminals were serotonin
- interfaced with brain neurons. [text elided]
- Later, Ricarte and, in a separate study, Dr. Stephan Peroutka of Stanford
- University both administered spinal taps to humans in the hope that their
- results might inidcate whether the effects noted in rats with altered
- serotonin terminals might lead to lowered levels of serotonin in the brains
- of people. They examined human spinal fluid for levels of the serotonin
- metabolite 5HIAA. Peroutka's study showed no difference between the MDMA
- users and the contrl groups. Ricarte's experiment showed lowered serotonin
- in the MDMA group, but the study was crticized because it used people with
- back pain as the control group, and the fact that they had pain could itself
- have led to the differences discovered. This study is now being repeated
- with improved methodology. But so far no solid scientific conclusions can be
- drawn from these spinal tap studies.
-
- p. 57: 5th and 6th paragraphs, 2nd column
- Another important point is that lowered serotonin levels produce no known
- behavioural changes in humans. One study showed very slight changes in
- performances in rats on one of many tests given to them after huge and
- repeated doses of MDMA produced dramatic changes in serotonin levels. More
- important is a recent and still unpublished study by George Ricarte, in which
- normal human doses were administered to primates every two weeks for four
- months They showed no evidence of neurotoxicity.
- With millions of people having taken MDMA over a 20-year period, some more
- than several hundred times, there has never been a reported case of
- MDMA-caused brain damage. Not one single case.
-
- He then talks about dangers with MDMA for people with cardiac problems and
- people dying due to a combination of MDMA, high temperatures, continuous
- dancing, and dehydration.
-
- [Switzerland allows certain physicians to use psychedelics on patients.]
- p. 58: 2nd paragraph and quote, 2nd column
- Since then, five Swiss physicians have been granted permits to prescribe
- psychedelics, and many more have been trained and expect to be granted
- permits soon. These physicians administer MDMA and other mind-altering drugs
- to patients in the course of therapy, usually in group settings. Dr. Samuel
- Eidmer, M.D., the administrator of the project, reports:
-
- In our work with MDMA in psychotherapy so far, we have not observed
- any negative effects, either of a psychological or physical kind.
- The tremendous usefulness in healing severe psychological
- disturbances outweighs the occasional stress to the organism though
- these substances. [text elided]
- The suspicion of possible toxicity to the nervous system, which had
- been considered a possible side effect of MDMA, was not substantiated
- by our use of a therapeutic dosage of this substance. This finding,
- confirmed by recent scientific research not yet published, by George
- Ricarte, USA: Following the treatment of primates with therapeutic
- dosages, no damaging effects to the nervous system were observed.
-
- the quote goes on to say that MDMA should be "made available on a
- broader scale" and should not be on Schedule 1.
-
- This has multiple places that say Ecstasy/X/MDMA is not a neurotoxin. Do you
- have references that rebuke what I heavily quoted above?
-
- Think free!
- --
- Security Torin/Darren Stalder/Wolf
- or __ Internet: dstalder@gmuvax2.gmu.edu PGP2 key available.
- Freewill. \/ Bitnet: dstalder@gmuvax
- Choose. ATTnet: 1-703-845-1000
- Snail: 10310 Main St., Suite 110/Fairfax, VA/22030/USA
- DISCLAIMER: A society where such disclaimers are needed is saddening.
-
-